Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 07.09.2026 1 Childs Nerv Syst 4 Int J Radiat Oncol Biol Phys 8 J Neurooncol 1 J Neuropathol Exp Neurol 5 J Neurosurg 6 Neuro Oncol 2 Neuroradiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Childs Nerv Syst

1. NIELSEN SH, Foss-Skiftesvik J, Meling TR, Sehested AM, et al
   Laser interstitial thermal therapy in pediatric neurosurgery: a prospective nationwide study on indications, safety, and early outcomes.
   Childs Nerv Syst. 2026;42:351.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

2. CASES C, Latorre-Musoll A, Candela-Juan C, Valduvieco I, et al
   One Year After a Cyberattack: Lessons Learned and Dosimetric Analysis of Contingency Radiotherapy Plans.
   Int J Radiat Oncol Biol Phys. 2026;126:308-317.
   PubMed         Abstract available
   
   
3. HOSTLER B, Karunamuni R, Lebon M, Ohta J, et al
   Domain-Specific Cognition-Sparing Stereotactic Radiosurgery: A Novel Planning Approach for Functional Preservation.
   Int J Radiat Oncol Biol Phys. 2026;126:371-378.
   PubMed         Abstract available
   
   
4. THOMANN B, Fechter T, Fischer J, Runz A, et al
   Multicenter End-to-End Evaluation of Single-Isocenter Multitarget Stereotactic Radiosurgery Approaches: Accuracy and Plan Quality.
   Int J Radiat Oncol Biol Phys. 2026;126:520-532.
   PubMed         Abstract available
   
   
5. WANG D, Lee SH, Wang T, Xiao Y, et al
   Assessment of Defacing Techniques on Medical Images for Radiation Therapy: Implications for Patient Privacy and Data Utility.
   Int J Radiat Oncol Biol Phys. 2026;126:502-519.
   PubMed         Abstract available
   
   

   
   J Neurooncol

6. BARDHAN M, Paul S, Pun S, Aryal MR, et al
   Integrating ex vivo platforms with AI to guide glioblastoma treatment.
   J Neurooncol. 2026;179:70.
   PubMed         Abstract available
   
   
7. EZAKI T, Tamura R, Yamamoto Y, Takei J, et al
   Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.
   J Neurooncol. 2026;179:69.
   PubMed         Abstract available
   
   
8. REYES JS, Hadjipanayis CG, Lunsford LD, Niranjan A, et al
   Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS (THINKERS): a mixture-of-experts framework for gastrointestinal brain metastases.
   J Neurooncol. 2026;179:68.
   PubMed         Abstract available
   
   
9. RUGGIERO A, Attina G, Placidi G, D'Agostino E, et al
   Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.
   J Neurooncol. 2026;179:67.
   PubMed         Abstract available
   
   
10. YU Z, Huang G, Yang G, Chang Q, et al
    alpha-Synuclein suppresses glioma progression through the CDH13-JNK/c-Jun pathway.
    J Neurooncol. 2026;179:66.
    PubMed         Abstract available
    
    
11. MUNIR M, Sehrawat K, Hassan H, Hall M, et al
    Survival and hematologic toxicity after whole-brain radiotherapy, photon craniospinal irradiation, and proton craniospinal irradiation for solid-tumor leptomeningeal disease: a systematic review.
    J Neurooncol. 2026;179:64.
    PubMed         Abstract available
    
    
12. SARKAR S, Vijayaraghavan S, Thakar S, Aryan S, et al
    Extent of resection and craniopharyngioma recurrence: a volumetric analysis.
    J Neurooncol. 2026;179:65.
    PubMed         Abstract available
    
    
13. SCHEICHEL F, Pinggera D, Rossmann T, Popadic B, et al
    Radiological response of primary central nervous system lymphoma after corticosteroid therapy and its predictive value on overall survival: a multicenter study.
    J Neurooncol. 2026;179:63.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

14. MACKEY T, Salovesh S, Tsung AJ, Carter A, et al
    Glioblastoma with ependymal-like features harboring novel CTDSP2::GLI1 and INHBE::GLI1 fusions.
    J Neuropathol Exp Neurol. 2026 Sep 2:nlag073. doi: 10.1093.
    PubMed        
    
    

    
    J Neurosurg

15. WANG DP, Liu YT, Dai YT, Chen S, et al
    Immune and clinicopathological features of molecularly defined prolactinoma subtypes.
    J Neurosurg. 2026;145:671-681.
    PubMed         Abstract available
    
    
16. ZHANG Z, Yin J, Hu M, He J, et al
    A nomogram predicting postoperative recurrence risk in SF1/TPIT nonfunctioning pituitary neuroendocrine tumors: integration of tumor heterogeneity quantification on T2-weighted imaging.
    J Neurosurg. 2026 Jun 26:1-10. doi: 10.3171/2026.1.JNS251071.
    PubMed         Abstract available
    
    
17. ABOU-AL-SHAAR H, Albalkhi I, Garcia JH, Peto I, et al
    Endoscopic endonasal and transcranial approaches to sellar/suprasellar arachnoid cysts: indications and outcomes.
    J Neurosurg. 2026 Jun 5:1-6. doi: 10.3171/2026.1.JNS251728.
    PubMed         Abstract available
    
    
18. KIM LJ, Rennert RC, Couldwell WT
    The risk of cerebrospinal fluid rhinorrhea from early resumption of positive pressure ventilation after transsphenoidal surgery with autologous fat graft repair.
    J Neurosurg. 2026 May 29:1-10. doi: 10.3171/2026.1.JNS251476.
    PubMed         Abstract available
    
    
19. PEERAN Z, Shukla P, Tummala T, Kabir A, et al
    Prognostic value of postoperative day 1 prolactin following prolactinoma resection.
    J Neurosurg. 2026;145:655-670.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

20. BLOBNER J, Schmidbauer KJ, Muther M, Roll W, et al
    Identification of prognostically relevant residual tumor in glioblastoma after surgery: A comparative analysis of MR-based RANO resect classes vs. [18F]FET PET.
    Neuro Oncol. 2026 Sep 4:noag212. doi: 10.1093.
    PubMed         Abstract available
    
    
21. YU X, Wu R, Huang T, Tiek D, et al
    EGFR-co-amplified lncRNA ELDR drives glioblastoma tumorigenicity by enhancing BMI1 activity.
    Neuro Oncol. 2026 Sep 3:noag213. doi: 10.1093.
    PubMed         Abstract available
    
    
22. SHEN F, Sheng H
    Molecular Testing and Reporting Completeness in Racial and Ethnic Glioma Disparities.
    Neuro Oncol. 2026 Sep 1:noag206. doi: 10.1093.
    PubMed        
    
    
23. MANKAME S, Beniwal AS, Dufault M, Nanda H, et al
    Cell-Free DNA Sequencing Captures Tumor Dynamics, Microenvironment Interactions, and Treatment Pressures in Glioblastoma.
    Neuro Oncol. 2026 Aug 31:noag204. doi: 10.1093.
    PubMed         Abstract available
    
    
24. TSAI YT, Mackert JD, Wilson A, Kooshki M, et al
    Cancer-intrinsic SIRPalpha Signaling Triggers Mitochondrial Fission and Immune Tolerance to Promote TNBC Breast-to-Brain Metastasis.
    Neuro Oncol. 2026 Aug 31:noag202. doi: 10.1093.
    PubMed         Abstract available
    
    
25. DENG B, Zhong X, Xin D, Huang X, et al
    A CAR-T Tonic Signaling Code Predicts Anti-Tumor Efficacy in Diffuse Midline Glioma.
    Neuro Oncol. 2026 Aug 31:noag205. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

26. PORTO L, Bison B, Karakas B, Kovacheva L, et al
    Assessment of paediatric craniopharyngioma progression: a comparison of contrast-enhanced and non-contrast MRI.
    Neuroradiology. 2026 Sep 1. doi: 10.1007/s00234-026-04154.
    PubMed         Abstract available
    
    
27. KESARI A, Gupta RK, Ahlawat S, Patir R, et al
    Non-invasive differentiation of diffuse midline glioma and midline glioblastoma using DCE-MRI perfusion parameters and machine learning classification in pediatric and young adult patients.
    Neuroradiology. 2026 Aug 31. doi: 10.1007/s00234-026-04156.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum